Xenetic Biosciences Files 8-K Amendment
Ticker: XBIO · Form: 8-K/A · Filed: Mar 19, 2025 · CIK: 1534525
| Field | Detail |
|---|---|
| Company | Xenetic Biosciences, Inc. (XBIO) |
| Form Type | 8-K/A |
| Filed Date | Mar 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, regulatory-filing, exhibit-update
TL;DR
Xenetic Biosciences filed an 8-K amendment to fix exhibits. No major news.
AI Summary
Xenetic Biosciences, Inc. filed an amendment (Amendment No. 1) to its Form 8-K on March 19, 2025. This filing primarily serves to correct or update previously filed exhibits, specifically referencing an exhibit filed on March 19, 2025. No new material events or financial information appear to be disclosed beyond the amendment of existing exhibits.
Why It Matters
This filing indicates a correction or update to previously submitted documents, suggesting a need for accuracy in regulatory filings. It does not introduce new strategic information.
Risk Assessment
Risk Level: low — The filing is an amendment to correct or update exhibits, not a disclosure of new material events, indicating low immediate risk.
Key Players & Entities
- Xenetic Biosciences, Inc. (company) — Registrant
- March 19, 2025 (date) — Filing date and earliest event date
- Amendment No. 1 (document) — Type of filing
- 001-37937 (document) — SEC File Number
- 45-2952962 (document) — IRS Employer Identification No.
FAQ
What is the primary purpose of this 8-K/A filing?
The primary purpose of this 8-K/A filing is to amend a previous filing, specifically to edit or update exhibits.
When was this amendment filed?
This amendment was filed on March 19, 2025.
What is the Commission File Number for Xenetic Biosciences, Inc.?
The Commission File Number for Xenetic Biosciences, Inc. is 001-37937.
What was Xenetic Biosciences, Inc. formerly known as?
Xenetic Biosciences, Inc. was formerly known as General Sales & Leasing, Inc. (name changed Feb 27, 2013) and GENERAL AIRCRAFT INC. (name changed Nov 8, 2011).
What is the principal executive office address for Xenetic Biosciences, Inc.?
The principal executive office address is 945 Concord Street, Framingham, Massachusetts 01701.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on March 19, 2025 regarding Xenetic Biosciences, Inc. (XBIO).